Innate IFN-γ promotes development of experimental autoimmune encephalomyelitis: A role for NK cells and M1 macrophages

European Journal of Immunology

Volumn 44, Issue 10, 2014, Pages 2903-2917

  Dungan, Lara S ^a   Mcguinness, Niamh C ^a   Boon, Louis ^b   Lynch, Marina A ^a   Mills, Kingston H G ^a  

^a TRINITY COLLEGE DUBLIN   (Ireland)

^b BIOCEROS   (Netherlands)

Author keywords

EAE; IFN ; Macrophage; NK cells; T cells

Indexed keywords

GAMMA INTERFERON; GRANULOCYTE MACROPHAGE COLONY STIMULATING FACTOR; INTERLEUKIN 17; MYELIN OLIGODENDROCYTE GLYCOPROTEIN; NEUTRALIZING ANTIBODY; VERY LATE ACTIVATION ANTIGEN 4;

ADOPTIVE TRANSFER; ANIMAL CELL; ANIMAL EXPERIMENT; ARTICLE; CELL ACTIVITY; CONTROLLED STUDY; CYTOKINE PRODUCTION; EXPERIMENTAL AUTOIMMUNE ENCEPHALOMYELITIS; IMMUNOCOMPETENT CELL; IN VITRO STUDY; LYMPHOCYTE TRANSFER; LYMPHOCYTIC INFILTRATION; MACROPHAGE; MOUSE; NATURAL KILLER CELL; NONHUMAN; PATHOGENESIS; PRIORITY JOURNAL; PROTEIN EXPRESSION; T CELL DEPLETION; ANIMAL; BIOSYNTHESIS; C57BL MOUSE; FLOW CYTOMETRY; IMMUNOLOGY; KNOCKOUT MOUSE; METABOLISM; NEUTROPHIL CHEMOTAXIS; REAL TIME POLYMERASE CHAIN REACTION; T LYMPHOCYTE;

ADOPTIVE TRANSFER; ANIMALS; CHEMOTAXIS, LEUKOCYTE; ENCEPHALOMYELITIS, AUTOIMMUNE, EXPERIMENTAL; FLOW CYTOMETRY; INTERFERON-GAMMA; KILLER CELLS, NATURAL; MACROPHAGES; MICE; MICE, INBRED C57BL; MICE, KNOCKOUT; REAL-TIME POLYMERASE CHAIN REACTION; T-LYMPHOCYTES;

EID: 84925269716     PISSN: 00142980     EISSN: 15214141     Source Type: Journal    
DOI: 10.1002/eji.201444612     Document Type: Article

References (29)

1. Panitch, H. S., Hirsch, R. L., Haley, A. S. and Johnson, K. P., Exacerbations of multiple sclerosis in patients treated with gamma interferon. Lancet 1987. 1: 893-895.
2. Renno, T., Taupin, V., Bourbonniere, L., Verge, G., Tran, E., De Simone, R., Krakowski, M. et al., Interferon-gamma in progression to chronic demyelination and neurological deficit following acute EAE. Mol. Cell. Neurosci. 1998. 12: 376-389.
3. Mills, K. H., Induction, function and regulation of IL-17-producing T cells. Eur. J. Immunol. 2008. 38: 2636-2649.
4. Kroenke, M. A., Carlson, T. J., Andjelkovic, A. V. and Segal, B. M., IL-12- and IL-23-modulated T cells induce distinct types of EAE based on histology, CNS chemokine profile, and response to cytokine inhibition. J. Exp. Med. 2008. 205: 1535-1541.
5. Gran, B., Zhang, G. X., Yu, S., Li, J., Chen, X. H., Ventura, E. S., Kamoun, M. and Rostami, A., IL-12p35-deficient mice are susceptible to experimental autoimmune encephalomyelitis: evidence for redundancy in the IL-12 system in the induction of central nervous system autoimmune demyelination. J. Immunol. 2002. 169: 7104-7110.
6. Becher, B., Durell, B. G. and Noelle, R. J., Experimental autoimmune encephalitis and inflammation in the absence of interleukin-12. J. Clin. Invest. 2002. 110: 493-497.
7. Zhang, G. X., Gran, B., Yu, S., Li, J., Siglienti, I., Chen, X., Kamoun, M. et al., Induction of experimental autoimmune encephalomyelitis in IL-12 receptor-beta 2-deficient mice: IL-12 responsiveness is not required in the pathogenesis of inflammatory demyelination in the central nervous system. J. Immunol. 2003. 170: 2153-2160.
8. Langrish, C. L., Chen, Y., Blumenschein, W. M., Mattson, J., Basham, B., Sedgwick, J. D., McClanahan, T. et al., IL-23 drives a pathogenic T cell population that induces autoimmune inflammation. J. Exp. Med. 2005. 201: 233-240.
9. Ferber, I. A., Brocke, S., Taylor-Edwards, C., Ridgway, W., Dinisco, C., Steinman, L., Dalton, D. et al., Mice with a disrupted IFN-gamma gene are susceptible to the induction of experimental autoimmune encephalomyelitis (EAE). J. Immunol. 1996. 156: 5-7.
10. Willenborg, D. O., Fordham, S., Bernard, C. C., Cowden, W. B. and Ramshaw, I. A., IFN-gamma plays a critical down-regulatory role in the induction and effector phase of myelin oligodendrocyte glycoprotein-induced autoimmune encephalomyelitis. J. Immunol. 1996. 157: 3223-3227.
11. Billiau, A., Heremans, H., Vandekerckhove, F., Dijkmans, R., Sobis, H., Meulepas, E. and Carton, H., Enhancement of experimental allergic encephalomyelitis in mice by antibodies against IFN-gamma. J. Immunol. 1988. 140: 1506-1510.
12. Duong, T. T., St Louis, J., Gilbert, J. J., Finkelman, F. D. and Strejan, G. H., Effect of anti-interferon-gamma and anti-interleukin-2 monoclonal antibody treatment on the development of actively and passively induced experimental allergic encephalomyelitis in the SJL/J mouse. J. Neuroimmunol. 1992. 36: 105-115.
13. Grifka-Walk, H. M., Lalor, S. J. and Segal, B. M., Highly polarized Th17 cells induce EAE via a T-bet independent mechanism. Eur. J. Immunol. 2013. 43: 2842-2831.
14. O'Connor, R. A., Prendergast, C. T., Sabatos, C. A., Lau, C. W., Leech, M. D., Wraith, D. C. and Anderton, S. M., Cutting edge: Th1 cells facilitate the entry of Th17 cells to the central nervous system during experimental autoimmune encephalomyelitis. J. Immunol. 2008. 181: 3750-3754.
15. Pribila, J. T., Quale, A. C., Mueller, K. L. and Shimizu, Y., Integrins and T cell-mediated immunity. Annu. Rev. Immunol. 2004. 22: 157-180.
16. Larochelle, C., Alvarez, J. I. and Prat, A., How do immune cells overcome the blood-brain barrier in multiple sclerosis? FEBS Lett. 2011. 585: 3770-3780.
17. Yednock, T. A., Cannon, C., Fritz, L. C., Sanchez-Madrid, F., Steinman, L. and Karin, N., Prevention of experimental autoimmune encephalomyelitis by antibodies against alpha 4 beta 1 integrin. Nature 1992. 356: 63-66.
18. Polman, C. H., O'Connor, P. W., Havrdova, E., Hutchinson, M., Kappos, L., Miller, D. H., Phillips, J. T. et al., A randomized, placebo-controlled trial of natalizumab for relapsing multiple sclerosis. N. Engl. J. Med. 2006. 354: 899-910.
19. Rothhammer, V., Heink, S., Petermann, F., Srivastava, R., Claussen, M. C., Hemmer, B. and Korn, T., Th17 lymphocytes traffic to the central nervous system independently of alpha4 integrin expression during EAE. J. Exp. Med. 2011. 208: 2465-2476.
20. Sutton, C. E., Lalor, S. J., Sweeney, C. M., Brereton, C. F., Lavelle, E. C. and Mills, K. H., Interleukin-1 and IL-23 induce innate IL-17 production from gammadelta T cells, amplifying Th17 responses and autoimmunity. Immunity 2009. 31: 331-341.
21. Sutton, C. E., Mielke, L. A. and Mills, K. H., IL-17-producing gammadelta T cells and innate lymphoid cells. Eur J Immunol. 2012. 42: 2221-2231.
22. Zhang, B., Yamamura, T., Kondo, T., Fujiwara, M. and Tabira, T., Regulation of experimental autoimmune encephalomyelitis by natural killer (NK) cells. J. Exp. Med. 1997. 186: 1677-1687.
23. Lu, L., Ikizawa, K., Hu, D., Werneck, M. B., Wucherpfennig, K. W. and Cantor, H., Regulation of activated CD4+ T cells by NK cells via the Qa-1-NKG2A inhibitory pathway. Immunity 2007. 26: 593-604.
24. Shi, F. D., Takeda, K., Akira, S., Sarvetnick, N. and Ljunggren, H. G., IL-18 directs autoreactive T cells and promotes autodestruction in the central nervous system via induction of IFN-gamma by NK cells. J Immunol 2000. 165: 3099-3104.
25. Mikita, J., Dubourdieu-Cassagno, N., Deloire, M. S., Vekris, A., Biran, M., Raffard, G., Brochet, B. et al., Altered M1/M2 activation patterns of monocytes in severe relapsing experimental rat model of multiple sclerosis. Amelioration of clinical status by M2 activated monocyte administration. Mult. Scler. 2011. 17: 2-15.
26. Jones, S. A., Sutton, C. E., Cua, D. and Mills, K. H., Therapeutic potential of targeting IL-17. Nat. Immunol. 2012. 13: 1022-1025.
27. El-Behi, M., Ciric, B., Dai, H., Yan, Y., Cullimore, M., Safavi, F., Zhang, G. X. et al., The encephalitogenicity of T(H)17 cells is dependent on IL-1- and IL-23-induced production of the cytokine GM-CSF. Nat. Immunol. 2011. 12: 568-575.
28. Codarri, L., Gyulveszi, G., Tosevski, V., Hesske, L., Fontana, A., Magnenat, L., Suter, T. et al., RORgammat drives production of the cytokine GM-CSF in helper T cells, which is essential for the effector phase of autoimmune neuroinflammation. Nat. Immunol. 2011. 12: 560-567.
29. Biswas, S. K. and Mantovani, A., Macrophage plasticity and interaction with lymphocyte subsets: cancer as a paradigm. Nat. Immunol. 2010. 11: 889-896.